A citation-based method for searching scientific literature

Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
Times Cited: 81



Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu, David E Goldgar, Mary Beth Terry, Matti A Rookus, Douglas F Easton, Antonis C Antoniou, Lesley McGuffog, D Gareth Evans, Daniel Barrowdale, Debra Frost, Julian Adlard, Kai-Ren Ong, Louise Izatt, Marc Tischkowitz, Ros Eeles, Rosemarie Davidson, Shirley Hodgson, Steve Ellis, Catherine Nogues, Christine Lasset, Dominique Stoppa-Lyonnet, Jean-Pierre Fricker, Laurence Faivre, Pascaline Berthet, Maartje J Hooning, Lizet E van der Kolk, Carolien M Kets, Muriel A Adank, Esther M John, Wendy K Chung, Irene L Andrulis, Melissa Southey, Mary B Daly, Saundra S Buys, Ana Osorio, Christoph Engel, Karin Kast, Rita K Schmutzler, Trinidad Caldes, Anna Jakubowska, Jacques Simard, Michael L Friedlander, Sue-Anne McLachlan, Eva Machackova, Lenka Foretova, Yen Y Tan, Christian F Singer, Edith Olah, Anne-Marie Gerdes, Brita Arver, Håkan Olsson. JAMA 2017
Times Cited: 760




List of shared articles



Times cited

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.
Noura S Abul-Husn, Emily R Soper, Jacqueline A Odgis, Sinead Cullina, Dean Bobo, Arden Moscati, Jessica E Rodriguez, Ruth J F Loos, Judy H Cho, Gillian M Belbin,[...]. Genome Med 2019
20

Feasibility and Assessment of a Cascade Traceback Screening Program (FACTS): Protocol for a Multisite Study to Implement and Assess an Ovarian Cancer Traceback Cascade Testing Program.
Anna DiNucci, Nora B Henrikson, M Cabell Jonas, Sundeep Basra, Paula Blasi, Jennifer Brown, Edward D Esplin, Dina Hassen, Jing Hao, Yirui Hu,[...]. J Pers Med 2021
0

Blending Insights from Implementation Science and the Social Sciences to Mitigate Inequities in Screening for Hereditary Cancer Syndromes.
Laura Senier, Colleen M McBride, Alex T Ramsey, Vence L Bonham, David A Chambers. Int J Environ Res Public Health 2019
0

Challenges and Opportunities in Engaging Primary Care Providers in BRCA Testing: Results from the BFOR Study.
Lydia E Pace, Nadine Tung, Yeonsoo S Lee, Jada G Hamilton, Camila Gabriel, Anna Revette, Sahitya Raja, Colby Jenkins, Anthony Braswell, Kelly Morgan,[...]. J Gen Intern Med 2021
0

An Overview of PARP Inhibitors for the Treatment of Breast Cancer.
Laura Cortesi, Hope S Rugo, Christian Jackisch. Target Oncol 2021
3

Attitudes towards risk-reducing early salpingectomy with delayed oophorectomy for ovarian cancer prevention: a cohort study.
F Gaba, O Blyuss, D Chandrasekaran, M Osman, S Goyal, C Gan, L Izatt, V Tripathi, I Esteban, L McNicol,[...]. BJOG 2021
1

Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.
Maija Reblin, Monica L Kasting, Kelli Nam, Courtney L Scherr, Jongphil Kim, Ram Thapa, Cathy D Meade, M Catherine Lee, Tuya Pal, Gwendolyn P Quinn,[...]. Breast J 2019
3

Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.
Ridgely Fisk Green, Mary Ari, Katherine Kolor, W David Dotson, Scott Bowen, Nancy Habarta, Juan L Rodriguez, Lisa C Richardson, Muin J Khoury. Genet Med 2019
16

The role of genomics in global cancer prevention.
Ophira Ginsburg, Patricia Ashton-Prolla, Anna Cantor, Daniela Mariosa, Paul Brennan. Nat Rev Clin Oncol 2021
3


Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers.
Deborah Cragun, Anne Weidner, Ann Tezak, Kate Clouse, Tuya Pal. Breast Cancer Res Treat 2020
3

The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.
Alicia A Tone, Jeanna M McCuaig, Nicole Ricker, Talin Boghosian, Tina Romagnuolo, Natalie Stickle, Carl Virtanen, Tong Zhang, Raymond H Kim, Sarah E Ferguson,[...]. Gynecol Oncol 2021
0


A systematic review of psycho-social interventions for individuals with a BRCA1/2 pathogenic variant.
Nikolett Zsuzsanna Warner, Soraya Matthews, AnnMarie Groarke, Jenny McSharry. J Genet Couns 2021
0

Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Gregory F Guzauskas, Shawn Garbett, Zilu Zhou, Scott J Spencer, Hadley S Smith, Jing Hao, Dina Hassen, Susan R Snyder, John A Graves, Josh F Peterson,[...]. JAMA Netw Open 2020
1